Chronic Spontaneous Urticaria Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Chronic Spontaneous Urticaria Market is segmented By Treatment (H1-antihistamines, H2 antihistamines, Monoclonal Antibodies, Corticosteroids, Leukotriene Receptor Antagonists), By Route of Administration (Oral, Subcutaneous, Intravenous), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Chronic Spontaneous Urticaria Market is segmented By Treatment (H1-antihistamines, H2 antihistamines, Monoclonal Antibodies, Corticosteroids, Leukotriene Receptor Antagon ....

Chronic Spontaneous Urticaria Market Size

Market Size in USD

CAGR10.7%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	10.7%
Market Concentration	Medium
Major Players	Roche, Novartis, Sanofi/Regeneron, AstraZeneca, Amgen

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Chronic Spontaneous Urticaria Market Analysis

The chronic spontaneous urticaria market is estimated to be valued at USD 2.4 Bn in 2024 and is expected to reach USD 4.88 Bn by 2031, growing at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2031. The increasing prevalence of chronic spontaneous urticaria and growing awareness about its treatment options are contributing to the growth of this market.

Chronic Spontaneous Urticaria Market Report Snapshots

Buy Now